Punjab, April 29 -- ANDERNACH, Germany, April 29, 2026 /PRNewswire/ - LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS' Lakewood, New Jersey facility. The new offering focuses initially on product development through clinical manufacturing of sterile ophthalmic products, filled in preservative-free multidose devices. Leveraging its established commercial aseptic manufacturing capabilities in nasal sprays and vials, LTS is well positioned to meet the high quality and regulator...